Jan 21, 2009 - King Pharmaceuticals, Inc. reported today that the U.S. District Court for the Eastern District of New York in the case of King Pharmaceuticals, Inc., et al. v. Eon Labs, Inc., Case No. 04-cv-5540 (DGT), issued an Order invalidating United States Patent Nos. 6,407,128 and 6,683,102, two patents relating to SKELAXIN (metaxalone).
The details can be read here.
No comments:
Post a Comment